Skip to main content

Table 4 Intermediate precision of Tezacaftor in mobile phase and human plasma

From: A rapid RP-HPLC method for the simultaneous estimation of Ivacaftor and Tezacaftor and in silico study of their metabolitic products

S. no.

Conc (μg/mL)

Mobile phase

Human plasma

Conc found

(μg/mL)

%

Avg %

Conc found

(μg/mL)

%

Avg %

1

30

30.7

102.3

101.5

30.69

102.3

101.8

2

30.52

101.7

30.48

101.6

3

30.22

100.7

30.57

101.9

4

30.32

101.0

30.50

101.6

5

30.49

101.6

30.55

101.8

6

30.52

101.7

30.52

101.7

S.D

 

0.021

 

0.03

% R.S.D

 

0.06

 

0.09